{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"selank-gabapentin","title":"Selank for Gabapentin Users: Anxiety Layer Evidence Review","body":"## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring normal function. Chronic use can involve tolerance to the masking effect. Some users report ongoing anxiety or non-restorative arousal states that persist alongside the drug. The core issue remains a mismatch where breakdown signals outpace any repair processes in neural tissue.\n\n## Why Selank might help you\n\n1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nIf your anxiety or arousal issues form a distinct layer separate from the pain signal that gabapentin addresses, the peptide's studied effects on GABA-related modulation could align with that specific layer.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce immediate mechanical or sensory load from pain but trades off by leaving the underlying nerve state unaddressed. For readers focused on regeneration pathways, this means the drug handles one symptom layer while repair mechanisms in other layers remain the focus of discussion.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Selank** → anxiety / neurochemistry\n\nSelank maps to the anxiety and neurochemistry layer. Gabapentin maps to signal suppression. The two address distinct layers without overlap in studied mechanisms.\n\n## What the evidence actually shows\n\nHuman data on Selank comes from small Russian trials in generalized anxiety disorder. One 2008 study compared Selank to medazepam in 62 patients with GAD and neurasthenia (human tier). Anxiety scores improved comparably, with Selank showing no sedation or withdrawal (human). A 2015 study of 70 patients found Selank plus benzodiazepine improved outcomes with fewer side effects (human). Rat studies show Selank alters expression of genes tied to neurotransmission and GABA binding in frontal cortex after intranasal dosing (preclinical). No human trials examine Selank specifically with gabapentin or pregabalin.\n\n## What scientists say\n\nResearchers note Selank produces anxiolytic effects similar to low-dose benzodiazepines via possible allosteric effects on GABA-A receptors but without amnesia, dependence, or sedation (mechanistic from gene and binding studies). Effects appear in both clinical observations and animal gene expression data. Large Western RCTs are absent.\n\n## What people say on Reddit\n\nUsers mention Selank for anxiety while on or tapering other GABAergic agents. Some report it helped with anxiety without the tolerance seen with gabapentin or phenibut (anecdotal). Others note paradoxical anxiety or no benefit (anecdotal). Discussions often separate Selank from direct gabapentin interactions.\n\n## What people say on X\n\nLimited posts tie Selank directly to gabapentin. General mentions highlight its use for anxiety reduction without sedation in nootropic communities (anecdotal).\n\n## What we do not know\n\nNo data exist on combined use with gabapentin. Long-term human safety beyond weeks to months remains unstudied in large populations. Individual response variability seen in small trials is not characterized for this cross.\n\n## Safety and limits\n\nSelank shows a profile without classic benzodiazepine drawbacks in available reports. All evidence remains limited to small samples or animal models. Readers should weigh the absence of large-scale human data on the specific combination.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/selank-gabapentin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"A 2008 Russian study of 62 patients found Selank produced anxiolytic effects comparable to medazepam in GAD without sedation or withdrawal.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human evidence base for Selank anxiolytic action separate from benzodiazepine side effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Selank alters gene expression related to GABAergic neurotransmission in rat frontal cortex after intranasal administration.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Supports mechanistic discussion of GABA modulation in animal models.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No published human trials examine Selank combined with gabapentin or pregabalin.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights the specific evidence gap for this drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"2008 study comparing Selank to medazepam in 62 GAD/neurasthenia patients; comparable efficacy noted.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:45:02.263Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"02347a7aafd34b499567efb3557ec9d83ac6545996996f11370fdee46ccafae1"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"We found significant changes in the expression of 45 genes 1 h after the administration of the compounds.","summary":"Rat study showing Selank changes neurotransmission gene expression in frontal cortex.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:45:02.263Z","link_status":"ok","quote_status":"verified","prev":"02347a7aafd34b499567efb3557ec9d83ac6545996996f11370fdee46ccafae1","hash":"ab5d417f5896f2d6337684cad0185604974118a576afe56d859bb12691a3a82e"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:45:02.886Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Selank for Gabapentin Users: Anxiety Layer Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring normal function. Chronic use can involve tolerance to the masking effect. Some users report ongoing anxiety or non-restorative arousal states that persist alongside the drug. The core issue remains a mismatch where breakdown signals outpace any repair processes in neural tissue.\n\n## Why Selank might help you\n\n1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nIf your anxiety or arousal issues form a distinct layer separate from the pain signal that gabapentin addresses, the peptide's studied effects on GABA-related modulation could align with that specific layer.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce immediate mechanical or sensory load from pain but trades off by leaving the underlying nerve state unaddressed. For readers focused on regeneration pathways, this means the drug handles one symptom layer while repair mechanisms in other layers remain the focus of discussion.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Selank** → anxiety / neurochemistry\n\nSelank maps to the anxiety and neurochemistry layer. Gabapentin maps to signal suppression. The two address distinct layers without overlap in studied mechanisms.\n\n## What the evidence actually shows\n\nHuman data on Selank comes from small Russian trials in generalized anxiety disorder. One 2008 study compared Selank to medazepam in 62 patients with GAD and neurasthenia (human tier). Anxiety scores improved comparably, with Selank showing no sedation or withdrawal (human). A 2015 study of 70 patients found Selank plus benzodiazepine improved outcomes with fewer side effects (human). Rat studies show Selank alters expression of genes tied to neurotransmission and GABA binding in frontal cortex after intranasal dosing (preclinical). No human trials examine Selank specifically with gabapentin or pregabalin.\n\n## What scientists say\n\nResearchers note Selank produces anxiolytic effects similar to low-dose benzodiazepines via possible allosteric effects on GABA-A receptors but without amnesia, dependence, or sedation (mechanistic from gene and binding studies). Effects appear in both clinical observations and animal gene expression data. Large Western RCTs are absent.\n\n## What people say on Reddit\n\nUsers mention Selank for anxiety while on or tapering other GABAergic agents. Some report it helped with anxiety without the tolerance seen with gabapentin or phenibut (anecdotal). Others note paradoxical anxiety or no benefit (anecdotal). Discussions often separate Selank from direct gabapentin interactions.\n\n## What people say on X\n\nLimited posts tie Selank directly to gabapentin. General mentions highlight its use for anxiety reduction without sedation in nootropic communities (anecdotal).\n\n## What we do not know\n\nNo data exist on combined use with gabapentin. Long-term human safety beyond weeks to months remains unstudied in large populations. Individual response variability seen in small trials is not characterized for this cross.\n\n## Safety and limits\n\nSelank shows a profile without classic benzodiazepine drawbacks in available reports. All evidence remains limited to small samples or animal models. Readers should weigh the absence of large-scale human data on the specific combination.","claims":[{"id":"c1","text":"A 2008 Russian study of 62 patients found Selank produced anxiolytic effects comparable to medazepam in GAD without sedation or withdrawal.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human evidence base for Selank anxiolytic action separate from benzodiazepine side effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Selank alters gene expression related to GABAergic neurotransmission in rat frontal cortex after intranasal administration.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Supports mechanistic discussion of GABA modulation in animal models.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No published human trials examine Selank combined with gabapentin or pregabalin.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights the specific evidence gap for this drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"We found significant changes in the expression of 45 genes 1 h after the administration of the compounds.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":15916,"tokens_out":2388,"cost":0.025865,"prev_hash":"genesis","hash":"585c665e50b189ebc9f0ac1701838537a7145a451cded2248303c3bb00961b29"}],"provenance":[{"ts":"2026-06-30T00:45:02.886Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Gabapentin\nSlug: selank-gabapentin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Gabapentin / pregabalin\",\"condition_key\":\"gabapentin-lyrica\",\"primary_peptide\":\"selank\",\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Gabapentin / pregabalin\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\",\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n4. **Therefore for you:** If that layer is part o","response":"{\n  \"slug\": \"selank-gabapentin\",\n  \"title\": \"Selank for Gabapentin Users: Anxiety Layer Evidence Review\",\n  \"body\": \"## What's breaking down if you have Gabapentin / pregabalin\\n\\nGabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring normal function. Chronic use can involve tolerance to the masking effect. Some users report ongoing anxiety or non-restorative arousal states that persist alongside the drug. The core issue remains a mismatch where breakdown signals outpace any repair processes in neural tissue.\\n\\n## Why Selank might help you\\n\\n1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\\n\\nIf your anxiety or arousal issues form a distinct layer separate from the pain signal that gabapentin addresses, the peptide's studied effects on GABA-related modulation could align with that specific layer.\\n\\n## Why Gabapentin / pregabalin matters for you\\n\\n**Drug:** Gabapentin / pregabalin\\n\\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\\n\\n**Therefore for you:** This drug suppresses a signal. It can reduce immediate mechanical or sensory load from pain but trades off by leaving the underlying nerve state unaddressed. For readers focused on regeneration pathways, this means the drug handles one symptom layer while repair mechanisms in other layers remain the focus of discussion.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings t","tokens_in":15916,"tokens_out":2388,"cost":0,"prev":"genesis","hash":"9f3147d8d6250ffc90fb0c19a57aa918d6651fc0951f70fccc71f286b6f3a027"},{"ts":"2026-07-17T02:41:37.041Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-gabapentin","response":"25 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9f3147d8d6250ffc90fb0c19a57aa918d6651fc0951f70fccc71f286b6f3a027","hash":"e432574e262980beae875103d73749a97d273008becf06277f9a3bc7e08a09c2"}],"energy":{"passes":2,"tokens_in":15916,"tokens_out":2388,"tokens_total":18304,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e432574e262980beae875103d73749a97d273008becf06277f9a3bc7e08a09c2"},"posted_at":"2026-06-29T21:33:04.425Z","created_at":"2026-06-29T21:33:04.425Z","updated_at":"2026-07-17T02:41:37.041Z","machine":{"shape":"article.machine/v1","slug":"selank-gabapentin","kind":"article","read":{"human":"https://miscsubjects.com/a/selank-gabapentin","json":"https://miscsubjects.com/api/articles/selank-gabapentin","bundle":"https://miscsubjects.com/api/articles/selank-gabapentin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":2,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/selank-gabapentin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=selank-gabapentin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-gabapentin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-gabapentin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/selank-gabapentin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"selank-gabapentin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/selank-gabapentin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/selank-gabapentin","json":"/api/articles/selank-gabapentin","markdown":"/api/articles/selank-gabapentin/bundle?format=markdown","skill":"/api/articles/selank-gabapentin/skill","topology":"/api/articles/selank-gabapentin/topology","versions":"/api/articles/selank-gabapentin/revisions","invocations":"/api/articles/selank-gabapentin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"selank-gabapentin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"ee165687c71df12cae7dfc499bd26cf93357b6bb9f16218341883348304c06d0","object":{"object_type":"article-object","identity":{"id":"article:selank-gabapentin","slug":"selank-gabapentin","title":"Selank for Gabapentin Users: Anxiety Layer Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/selank-gabapentin","role":"explain","audience":"human"},"skill":{"route":"/api/articles/selank-gabapentin/skill","role":"direct behavior","audience":"model","content":"---\nname: selank-gabapentin\ndescription: Apply the Selank for Gabapentin Users: Anxiety Layer Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Selank for Gabapentin Users: Anxiety Layer Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/selank-gabapentin). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/selank-gabapentin.\n- Read claims and relationships at /api/articles/selank-gabapentin/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Gabapentin / pregabalin Gabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring norma\n\n## Representations\n\n- Human: /a/selank-gabapentin\n- JSON: /api/articles/selank-gabapentin\n- Relationships: /api/articles/selank-gabapentin/topology\n- History: /api/articles/selank-gabapentin/revisions\n"},"json":{"route":"/api/articles/selank-gabapentin","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/selank-gabapentin/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","selank","gabapentin"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/selank-gabapentin/invocations?status=success","failure_events":"/api/articles/selank-gabapentin/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"selank-gabapentin","title":"Selank for Gabapentin Users: Anxiety Layer Evidence Review","body":"## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring normal function. Chronic use can involve tolerance to the masking effect. Some users report ongoing anxiety or non-restorative arousal states that persist alongside the drug. The core issue remains a mismatch where breakdown signals outpace any repair processes in neural tissue.\n\n## Why Selank might help you\n\n1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nIf your anxiety or arousal issues form a distinct layer separate from the pain signal that gabapentin addresses, the peptide's studied effects on GABA-related modulation could align with that specific layer.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce immediate mechanical or sensory load from pain but trades off by leaving the underlying nerve state unaddressed. For readers focused on regeneration pathways, this means the drug handles one symptom layer while repair mechanisms in other layers remain the focus of discussion.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Selank** → anxiety / neurochemistry\n\nSelank maps to the anxiety and neurochemistry layer. Gabapentin maps to signal suppression. The two address distinct layers without overlap in studied mechanisms.\n\n## What the evidence actually shows\n\nHuman data on Selank comes from small Russian trials in generalized anxiety disorder. One 2008 study compared Selank to medazepam in 62 patients with GAD and neurasthenia (human tier). Anxiety scores improved comparably, with Selank showing no sedation or withdrawal (human). A 2015 study of 70 patients found Selank plus benzodiazepine improved outcomes with fewer side effects (human). Rat studies show Selank alters expression of genes tied to neurotransmission and GABA binding in frontal cortex after intranasal dosing (preclinical). No human trials examine Selank specifically with gabapentin or pregabalin.\n\n## What scientists say\n\nResearchers note Selank produces anxiolytic effects similar to low-dose benzodiazepines via possible allosteric effects on GABA-A receptors but without amnesia, dependence, or sedation (mechanistic from gene and binding studies). Effects appear in both clinical observations and animal gene expression data. Large Western RCTs are absent.\n\n## What people say on Reddit\n\nUsers mention Selank for anxiety while on or tapering other GABAergic agents. Some report it helped with anxiety without the tolerance seen with gabapentin or phenibut (anecdotal). Others note paradoxical anxiety or no benefit (anecdotal). Discussions often separate Selank from direct gabapentin interactions.\n\n## What people say on X\n\nLimited posts tie Selank directly to gabapentin. General mentions highlight its use for anxiety reduction without sedation in nootropic communities (anecdotal).\n\n## What we do not know\n\nNo data exist on combined use with gabapentin. Long-term human safety beyond weeks to months remains unstudied in large populations. Individual response variability seen in small trials is not characterized for this cross.\n\n## Safety and limits\n\nSelank shows a profile without classic benzodiazepine drawbacks in available reports. All evidence remains limited to small samples or animal models. Readers should weigh the absence of large-scale human data on the specific combination.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/selank-gabapentin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"A 2008 Russian study of 62 patients found Selank produced anxiolytic effects comparable to medazepam in GAD without sedation or withdrawal.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human evidence base for Selank anxiolytic action separate from benzodiazepine side effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Selank alters gene expression related to GABAergic neurotransmission in rat frontal cortex after intranasal administration.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Supports mechanistic discussion of GABA modulation in animal models.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No published human trials examine Selank combined with gabapentin or pregabalin.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights the specific evidence gap for this drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"2008 study comparing Selank to medazepam in 62 GAD/neurasthenia patients; comparable efficacy noted.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:45:02.263Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"02347a7aafd34b499567efb3557ec9d83ac6545996996f11370fdee46ccafae1"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"We found significant changes in the expression of 45 genes 1 h after the administration of the compounds.","summary":"Rat study showing Selank changes neurotransmission gene expression in frontal cortex.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:45:02.263Z","link_status":"ok","quote_status":"verified","prev":"02347a7aafd34b499567efb3557ec9d83ac6545996996f11370fdee46ccafae1","hash":"ab5d417f5896f2d6337684cad0185604974118a576afe56d859bb12691a3a82e"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:45:02.886Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Selank for Gabapentin Users: Anxiety Layer Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring normal function. Chronic use can involve tolerance to the masking effect. Some users report ongoing anxiety or non-restorative arousal states that persist alongside the drug. The core issue remains a mismatch where breakdown signals outpace any repair processes in neural tissue.\n\n## Why Selank might help you\n\n1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nIf your anxiety or arousal issues form a distinct layer separate from the pain signal that gabapentin addresses, the peptide's studied effects on GABA-related modulation could align with that specific layer.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce immediate mechanical or sensory load from pain but trades off by leaving the underlying nerve state unaddressed. For readers focused on regeneration pathways, this means the drug handles one symptom layer while repair mechanisms in other layers remain the focus of discussion.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **Selank** → anxiety / neurochemistry\n\nSelank maps to the anxiety and neurochemistry layer. Gabapentin maps to signal suppression. The two address distinct layers without overlap in studied mechanisms.\n\n## What the evidence actually shows\n\nHuman data on Selank comes from small Russian trials in generalized anxiety disorder. One 2008 study compared Selank to medazepam in 62 patients with GAD and neurasthenia (human tier). Anxiety scores improved comparably, with Selank showing no sedation or withdrawal (human). A 2015 study of 70 patients found Selank plus benzodiazepine improved outcomes with fewer side effects (human). Rat studies show Selank alters expression of genes tied to neurotransmission and GABA binding in frontal cortex after intranasal dosing (preclinical). No human trials examine Selank specifically with gabapentin or pregabalin.\n\n## What scientists say\n\nResearchers note Selank produces anxiolytic effects similar to low-dose benzodiazepines via possible allosteric effects on GABA-A receptors but without amnesia, dependence, or sedation (mechanistic from gene and binding studies). Effects appear in both clinical observations and animal gene expression data. Large Western RCTs are absent.\n\n## What people say on Reddit\n\nUsers mention Selank for anxiety while on or tapering other GABAergic agents. Some report it helped with anxiety without the tolerance seen with gabapentin or phenibut (anecdotal). Others note paradoxical anxiety or no benefit (anecdotal). Discussions often separate Selank from direct gabapentin interactions.\n\n## What people say on X\n\nLimited posts tie Selank directly to gabapentin. General mentions highlight its use for anxiety reduction without sedation in nootropic communities (anecdotal).\n\n## What we do not know\n\nNo data exist on combined use with gabapentin. Long-term human safety beyond weeks to months remains unstudied in large populations. Individual response variability seen in small trials is not characterized for this cross.\n\n## Safety and limits\n\nSelank shows a profile without classic benzodiazepine drawbacks in available reports. All evidence remains limited to small samples or animal models. Readers should weigh the absence of large-scale human data on the specific combination.","claims":[{"id":"c1","text":"A 2008 Russian study of 62 patients found Selank produced anxiolytic effects comparable to medazepam in GAD without sedation or withdrawal.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human evidence base for Selank anxiolytic action separate from benzodiazepine side effects.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Selank alters gene expression related to GABAergic neurotransmission in rat frontal cortex after intranasal administration.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Supports mechanistic discussion of GABA modulation in animal models.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"No published human trials examine Selank combined with gabapentin or pregabalin.","section":"What we do not know","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights the specific evidence gap for this drug cross.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:45:02.498Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"We found significant changes in the expression of 45 genes 1 h after the administration of the compounds.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":15916,"tokens_out":2388,"cost":0.025865,"prev_hash":"genesis","hash":"585c665e50b189ebc9f0ac1701838537a7145a451cded2248303c3bb00961b29"}],"provenance":[{"ts":"2026-06-30T00:45:02.886Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Gabapentin\nSlug: selank-gabapentin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Gabapentin / pregabalin\",\"condition_key\":\"gabapentin-lyrica\",\"primary_peptide\":\"selank\",\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Gabapentin / pregabalin\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\",\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n4. **Therefore for you:** If that layer is part o","response":"{\n  \"slug\": \"selank-gabapentin\",\n  \"title\": \"Selank for Gabapentin Users: Anxiety Layer Evidence Review\",\n  \"body\": \"## What's breaking down if you have Gabapentin / pregabalin\\n\\nGabapentin and pregabalin act on calcium channels to dampen excitatory signaling in nerves. This masks neuropathic pain signals rather than repairing damaged nerves or restoring normal function. Chronic use can involve tolerance to the masking effect. Some users report ongoing anxiety or non-restorative arousal states that persist alongside the drug. The core issue remains a mismatch where breakdown signals outpace any repair processes in neural tissue.\\n\\n## Why Selank might help you\\n\\n1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\\n\\nIf your anxiety or arousal issues form a distinct layer separate from the pain signal that gabapentin addresses, the peptide's studied effects on GABA-related modulation could align with that specific layer.\\n\\n## Why Gabapentin / pregabalin matters for you\\n\\n**Drug:** Gabapentin / pregabalin\\n\\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\\n\\n**Therefore for you:** This drug suppresses a signal. It can reduce immediate mechanical or sensory load from pain but trades off by leaving the underlying nerve state unaddressed. For readers focused on regeneration pathways, this means the drug handles one symptom layer while repair mechanisms in other layers remain the focus of discussion.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings t","tokens_in":15916,"tokens_out":2388,"cost":0,"prev":"genesis","hash":"9f3147d8d6250ffc90fb0c19a57aa918d6651fc0951f70fccc71f286b6f3a027"},{"ts":"2026-07-17T02:41:37.041Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-gabapentin","response":"25 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9f3147d8d6250ffc90fb0c19a57aa918d6651fc0951f70fccc71f286b6f3a027","hash":"e432574e262980beae875103d73749a97d273008becf06277f9a3bc7e08a09c2"}],"energy":{"passes":2,"tokens_in":15916,"tokens_out":2388,"tokens_total":18304,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e432574e262980beae875103d73749a97d273008becf06277f9a3bc7e08a09c2"},"posted_at":"2026-06-29T21:33:04.425Z","created_at":"2026-06-29T21:33:04.425Z","updated_at":"2026-07-17T02:41:37.041Z","machine":{"shape":"article.machine/v1","slug":"selank-gabapentin","kind":"article","read":{"human":"https://miscsubjects.com/a/selank-gabapentin","json":"https://miscsubjects.com/api/articles/selank-gabapentin","bundle":"https://miscsubjects.com/api/articles/selank-gabapentin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":2,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/selank-gabapentin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=selank-gabapentin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-gabapentin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-gabapentin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/selank-gabapentin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"selank-gabapentin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/selank-gabapentin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/selank-gabapentin","json":"/api/articles/selank-gabapentin","markdown":"/api/articles/selank-gabapentin/bundle?format=markdown","skill":"/api/articles/selank-gabapentin/skill","topology":"/api/articles/selank-gabapentin/topology","versions":"/api/articles/selank-gabapentin/revisions","invocations":"/api/articles/selank-gabapentin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"selank-gabapentin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"ee165687c71df12cae7dfc499bd26cf93357b6bb9f16218341883348304c06d0"}}}